STERIS plc (Ireland) (STE)
NYSE: STEHealth CareIndustrial SpecialtiesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
STE stock chart
Technical analysisKey statistics
All statistics- Market cap
- $20.44B
- P/E (TTM)
- 25.51
- Forward P/E
- 17.12
- EPS (TTM)
- $8.22
- Dividend yield
- 1.20% ($2.52)
- Ex-dividend date
- Sep 4, 2026
- 52-week range
- 195.14 – 269.44
- Day range
- 208.37 – 211.95
- Volume / Avg
- 669.83K / 694.18K
- Beta
- —
- Shares outstanding
- 97.50M
- Next earnings
- Nov 4, 2026
52-week range
STE stock today
STERIS (Ireland) (STE) closed at $209.68 on Oct 7, up 0.49% (+$1.03), versus the S&P 500's 0.22% decline. At this level, STE sits near the bottom of its 52-week range of $195.14 to $269.44: 22.2% below the high, set on Jan 16, 2026 and 7.5% above the low. STE is down 17.3% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 13.2%.
At 25.5x trailing earnings, STERIS (Ireland) trades above the peer-group median of 21.5x. Its forward P/E of 17.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. STERIS (Ireland)'s next earnings report is expected on Nov 4, 2026. STERIS (Ireland) pays an annual dividend of $2.52 per share, a 1.20% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About STERIS (Ireland)
Company profileSTERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services.
- Sector
- Health Care
- Industry
- Industrial Specialties
- CEO
- Mr. Daniel A. Carestio
- Headquarters
- Mentor, OH
- Employees
- 17,937
- Website
- steris.com
Financial highlights
Full financialsIn fiscal 2026, STERIS (Ireland) generated $5.94 billion in revenue, up 8.7% from fiscal 2025, its 9th consecutive year of revenue growth. Net income was $782.3 million (+27.3% year over year), for a net margin of 13.2% versus a median of 7.4% in the prior 5 years. Gross margin was 44.2% (up from 44.0%) and operating margin 18.6%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $5.94B | $5.46B | $5.14B | $4.54B | $4.22B |
| Growth | +8.73% | +6.24% | +13.28% | +7.41% | +35.91% |
| Net income | $782.30M | $614.60M | $378.20M | $107.03M | $243.89M |
| EPS (diluted) | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 |
Analyst forecast
ForecastConsensus (9 analysts)
buy
Avg. price target
$263.13+25.49%
- Strong buy 3
- Buy 4
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $2.67
- Last reported (Q1 2027)
- Aug 7, 2026
- EPS actual vs est.
- $2.04 vs —
Dividends
Dividend history- Annual dividend
- $2.52
- Dividend yield
- 1.20%
- Last payment
- $0.69
- Ex-dividend date
- Sep 4, 2026
STE news
All STE news- Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?NasdaqSTE, SYK, EW
- Should Investors Buy STERIS as Growth Meets Reasonable Valuation?NasdaqSTE, SYK, EW
- Ecolab Rallies 12.2% in 3 Months as High-Tech Growth Gains MomentumNasdaqECL, PNR, STE
- Waters (WAT) Q2 Earnings and Revenues Beat EstimatesNasdaqWAT, STE
STERIS (Ireland) peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ZBHZimmer Biomet Holdings Inc. | 88.49 | -1.33% | $16.88B | vs STE |
| MASMasco Corporation | 68.87 | -1.52% | $13.58B | vs STE |
| AITApplied Industrial Technologies Inc. | 334.58 | -3.02% | $12.29B | vs STE |
| SNNSmith & Nephew SNATS Inc. | 26.89 | +0.07% | $11.25B | vs STE |
| ALGNAlign Technology Inc. | 139.87 | -1.12% | $9.94B | vs STE |
| MTRNMaterion Corporation | 290.72 | -6.87% | $6.06B | vs STE |
| POOLPool Corporation | 154.14 | -2.59% | $5.60B | vs STE |
| AZZAZZ Inc. | 138.51 | -2.18% | $4.16B | vs STE |
Indexes, lists and sector
Index membership
Appears in lists
STERIS (Ireland) stock FAQ
What is STERIS (Ireland)'s stock price today?
STE last traded at $209.68 as of Oct 7, 4:00 PM EDT, up 0.49% on the day. Prices are delayed at least 15 minutes.
Does STERIS (Ireland) pay a dividend?
Yes. STERIS (Ireland) pays $2.52 per share annually, a 1.20% yield. The most recent dividend of $0.69 had an ex-dividend date of Sep 4, 2026.
When is STERIS (Ireland)'s next earnings date?
STERIS (Ireland) is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $2.67.
What is STE's P/E ratio?
STE trades at a trailing P/E ratio of 25.51 and a forward P/E of 17.12, compared with a median of 21.5 for its closest peers.
Is STERIS (Ireland) in the S&P 500?
Yes. STERIS (Ireland) (STE) is a constituent of the S&P 500 index.
Who is STERIS (Ireland)'s CEO?
Mr. Daniel A. Carestio is the chief executive officer of STERIS plc (Ireland), which has about 17,937 employees.
Has STE ever split its stock?
Yes. The most recent STE stock split was a 2-for-1 split on Aug 25, 1998, one of 2 splits on record.